Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 35.58M P/E - EPS this Y 41.40% Ern Qtrly Grth -
Income -42.2M Forward P/E -1.40 EPS next Y -13.10% 50D Avg Chg 1.00%
Sales - PEG -0.02 EPS past 5Y - 200D Avg Chg 10.00%
Dividend N/A Price/Book 1.49 EPS next 5Y 40.90% 52W High Chg -73.00%
Recommedations 1.30 Quick Ratio 6.13 Shares Outstanding 2.82M 52W Low Chg 327.00%
Insider Own 17.95% ROA -34.28% Shares Float 2.31M Beta -1.84
Inst Own 22.73% ROE -318.75% Shares Shorted/Prior 5.05K/12.07K Price 15.15
Gross Margin - Profit Margin - Avg. Volume 81,293 Target Price 19.33
Oper. Margin - Earnings Date May 7 Volume 123,403 Change 2.57%
About Kala Pharmaceuticals, Inc.

KALA BIO, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

KALA Chatroom

User Image Stockwaveinsights Posted - 2 days ago

Markets,$KALA https://www.stockwaveinsights.com/navigating-the-frontier-of-ocular-biotechnology-a-close-look-at-kala-bio-inc/

User Image Winnning Posted - 1 week ago

$KALA next is $HOLO

User Image WarrenBuffetOfficial1 Posted - 1 week ago

$MRNA $BNTX $PFIZER.NSE $KALA $MYMD VERU. VERU's revolutionary drug could be worth billions, remember it is already in advanced phase 2 .

User Image FetchDog Posted - 3 weeks ago

$KALA Sold most of my position today at $7.97. From the quarterly ER (filed march 29), they claim data at year-end 2024 (instead of 2024-H2). That means they are having delays completing enrollment for their P2 trial. Makes sense, because they have a wide range of PCED conditions in their trial. It will take at about 9 months after completion of enrollment to generate the data from their P2 trial. So that means data in 2025, not year end 2024 as they claim in their ER. So they are lying, pushing back dates, typical for biotech. That's why the Baker Bros. recently invested some cash in the company - to prevent the stock from sliding too much. I plan to rebuy in about a month or two, hopefully at a better price.

User Image Fullratio Posted - 3 weeks ago

$KALA quick ratio has soared by 123% YoY and by 12% from the previous quarter: https://fullratio.com/stocks/nasdaq-kala/kala-pharmaceuticals

User Image ozkanman Posted - 3 weeks ago

$HSDT $AVTX $KALA $SRZN $MULN

User Image tradingtwenty Posted - 3 weeks ago

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $HSDT 5.17M 🔥 $AVTX 17.44M $KALA 21.46M $SRZN 32.02M $MULN 34.07M Link: https://tradingtwenty.com/dashboard/trending/past

User Image Stock_Titan Posted - 03/29/24

$KALA KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/KALA/kala-bio-reports-fourth-quarter-and-full-year-2023-financial-results-0cilxvtdn75c.html

User Image Stockwaveinsights Posted - 03/28/24

$A, $KALA Innovative Frontiers: Agilent Technologies And Kala Bio Spearhead Healthcare Breakthroughs https://www.stockwaveinsights.com/

User Image FetchDog Posted - 03/27/24

$KALA Keep in mind another possibility, that the investment was made now before the upcoming ER to protect the cash runway because the enrollment in their phase 2b trial is dragging on. They wanted to inject cash before the ER to prevent investors from worrying about the cash runway, which would cause a drastic drop in the stock price and make it difficult to raise cash at a later date.

User Image FetchDog Posted - 03/27/24

$KALA From SEC, on march 25, Baker Bros. and their client "557 L.P." entered into a purchase agreement with Kala to purchase $8,599,798.90 of series G non-voting preferred convertible securities. The "conversion price" of common used for conversion is $7.889 (i.e. as if they purchased common shares at $7.889). This transaction keeps Baker Bros. below the 10% limit until they convert. For me, this is a very positive development. I interpret it as Kala doing a favor to their main shareholder, selling them some cheap shares before the stock price rises. The 23-Q1 earnings report is due by this Friday. Will it contain good news, such as the completion enrollment in Phase 2b KPI-012 for PCED? Interesting the stock price didn't budge, no volume, nothing. Nobody is watching this gem. I have my shares, this is a waiting game.

User Image robo84 Posted - 03/27/24

$AKBA Come on bring it to 2,50$ before the PFDUFA news out today ...⏰🚀🚀 $KALA $BNGO

User Image Stockwaveinsights Posted - 03/27/24

$PSO, $KALA Pioneering The Future: KALA BIO And Pearson Plc. Forge Ahead In Biopharmaceutical And Educational Frontiers https://www.stockwa

User Image Stockwaveinsights Posted - 03/27/24

$KALA Pioneering The Future Of Ocular Therapeutics: A Glimpse Into KALA BIO, Inc.'s Endeavors https://www.stockwaveinsights.com/

User Image Stockwaveinsights Posted - 1 month ago

$BTC, $TSLA, $KALA Industry Dynamics: Tesla's Workforce Decisions, Regulatory Shifts and KALA BIO's Clinical Progress https://www.stockwave

User Image Stockwaveinsights Posted - 1 month ago

$BTC, $TSLA, $A, $KALA Industry Dynamics: Tesla's Workforce Decisions, Agilent's Leadership Moves and KALA's Clinical Progress https://www.

User Image Stockwaveinsights Posted - 1 month ago

$A, $TSLA, $KALA, $ROIC Corporate Dynamics: Agilent, Tesla, KALA BIO and ROIC Navigate Market Complexities https://www.stockwaveinsights.co

User Image robo84 Posted - 1 month ago

$SLS The closing of the Offering is expected to occur on or about March 19, 2024, subject to the satisfaction of customary closing conditions. After the 19th the data will be published, could happen this week.💫💢 $TERN $KALA

User Image EDayTrade Posted - 1 month ago

$KALA Looks like we are still 8 days away from earnings on 03/22. They were supposed to report on 03/15. Any idea what might happen?

User Image tradingtwenty Posted - 1 month ago

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $VERB 9.39M 🔥 $JOANQ 9.66M $GHSI 10.35M $ADXN 12.41M $KALA 20.28M Link: https://tradingtwenty.com/dashboard/trending/past

User Image dannosmith Posted - 1 month ago

$KALA Still overvalued.

User Image induscapital Posted - 1 month ago

$RGLS $KALA $TPST kind of feeling

User Image ANTHONYMOMO Posted - 1 month ago

$KALA small float play

User Image johsmith Posted - 1 month ago

$KALA just bought a handful

User Image MRCOCO69 Posted - 02/29/24

$KALA keep buying... Hoping for a pop. This is one of the biggest scams in all of bios history. Just zoom out the chart

User Image muskegbaymomentum Posted - 02/27/24

$KALA watching KALA . We all remember the last huge run.

User Image Ninja_Tradez Posted - 1 month ago

📢 $KALA - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference https://newsfilter.io/a/8a678fd8bfaeb06015d9d88c881eb1bf

User Image Stock_Titan Posted - 1 month ago

$KALA KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference https://www.stocktitan.net/news/KALA/kala-bio-to-present-at-td-cowen-44th-annual-healthcare-01ccinpsq4gz.html

User Image Okonomiyaki Posted - 2 months ago

$KALA I think I love you…🕳️🧑‍🦯

User Image RamenLives Posted - 2 months ago

$KALA In!

Analyst Ratings
HC Wainwright & Co. Buy Apr 2, 24
Oppenheimer Outperform Apr 1, 24
HC Wainwright & Co. Buy Nov 17, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy May 10, 23
HC Wainwright & Co. Buy May 1, 23
HC Wainwright & Co. Buy Apr 12, 23
HC Wainwright & Co. Buy Mar 27, 23
HC Wainwright & Co. Buy Mar 6, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Trachtenberg Eric SEE REMARKS SEE REMARKS Jan 04 Sell 28.55 60 1,713 11,495 01/06/23
Reumuth Mary CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jan 04 Sell 28.54 60 1,712 11,883 01/06/23
Brazzell Romulus K SEE REMARKS SEE REMARKS Jan 04 Sell 28.53 73 2,083 18,536 01/06/23
Bazemore Todd SEE REMARKS SEE REMARKS Jan 04 Sell 28.54 62 1,769 14,835 01/06/23
Iwicki Mark T CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jan 04 Sell 28.54 198 5,651 45,966 01/06/23
Trachtenberg Eric SEE REMARKS SEE REMARKS Jun 27 Sell 0.37 2,613 967 111,203 06/29/22
Reumuth Mary CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jun 27 Sell 0.37 2,613 967 130,595 06/29/22
Brazzell Romulus K SEE REMARKS SEE REMARKS Jun 27 Sell 0.37 3,144 1,163 285,201 06/29/22
Bazemore Todd SEE REMARKS SEE REMARKS Jun 27 Sell 0.37 3,092 1,144 115,499 06/29/22
Iwicki Mark T CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jun 27 Sell 0.37 7,975 2,951 251,183 06/29/22
RA CAPITAL MANAGEMENT, L.P. 10% Owner 10% Owner May 26 Sell 0.3636 1,005,686 365,667 7,039,613 05/26/22
RA CAPITAL MANAGEMENT, L.P. 10% Owner 10% Owner May 23 Sell 0.53 2,829,314 1,499,536 8,045,299 05/25/22
Chen Hongming CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Oct 26 Sell 1.81 30,500 55,205 204,515 10/28/21